Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K McCoy

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
Biorxiv : the Preprint Server for Biology|January 3, 2024
GSK3 inhibition reduces ECM production and prevents age-related macular degeneration-like pathologySophia M DiCesare, Antonio J Ortega, Gracen E Collier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 10, 2001
Rapid peptide turnover and inefficient presentation of exogenous antigen critically limit the activation of self-reactive CTL by dendritic cellsB Ludewig, K McCoy, M Pericin, et al.
American Journal of Pharmaceutical Education|February 9, 2025
Impact of Curricular Content Reduction on Student-Reported Mental and Physical HealthTaylor D Steuber, Daniel J Trujillo, Erika L Kleppinger, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 15, 2006
Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's diseaseMelissa K McCoy, Terina N Martinez, Kelly A Ruhn, et al.
Experimental Neurology|December 7, 2007
Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's diseaseMelissa K McCoy, Terina N Martinez, Kelly A Ruhn, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|October 10, 2006
Smectic-Calpha*-smectic-C* phase transition and critical point in binary mixturesZ Q Liu, S T Wang, B K McCoy, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2000
1,3-Diarylcycloalkanopyrazoles and diphenyl hydrazides as selective inhibitors of cyclooxygenase-2Z Sui, J Guan, M P Ferro, et al.
Insight (American Society of Ophthalmic Registered Nurses)|April 1, 1994
Travelogue--St. Petersburg & Moscow, Russia and London, EnglandK McCoy, P S Schremps, L S Elfervig, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?Malú G Tansey, Tamy C Frank-Cannon, Melissa K McCoy, et al.
ACS Sensors|July 21, 2017
Correction to Insulin Promoter-Driven Gaussia Luciferase-Based Insulin Secretion Biosensor Assay for Discovery of β-Cell Glucose-Sensing PathwaysMichael A Kalwat, Chonlarat Wichaidit, Alejandra Y Nava Garcia, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Biorxiv : the Preprint Server for Biology|January 3, 2024
GSK3 inhibition reduces ECM production and prevents age-related macular degeneration-like pathologySophia M DiCesare, Antonio J Ortega, Gracen E Collier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 10, 2001
Rapid peptide turnover and inefficient presentation of exogenous antigen critically limit the activation of self-reactive CTL by dendritic cellsB Ludewig, K McCoy, M Pericin, et al.
American Journal of Pharmaceutical Education|February 9, 2025
Impact of Curricular Content Reduction on Student-Reported Mental and Physical HealthTaylor D Steuber, Daniel J Trujillo, Erika L Kleppinger, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 15, 2006
Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's diseaseMelissa K McCoy, Terina N Martinez, Kelly A Ruhn, et al.
Experimental Neurology|December 7, 2007
Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's diseaseMelissa K McCoy, Terina N Martinez, Kelly A Ruhn, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|October 10, 2006
Smectic-Calpha*-smectic-C* phase transition and critical point in binary mixturesZ Q Liu, S T Wang, B K McCoy, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2000
1,3-Diarylcycloalkanopyrazoles and diphenyl hydrazides as selective inhibitors of cyclooxygenase-2Z Sui, J Guan, M P Ferro, et al.
Insight (American Society of Ophthalmic Registered Nurses)|April 1, 1994
Travelogue--St. Petersburg & Moscow, Russia and London, EnglandK McCoy, P S Schremps, L S Elfervig, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?Malú G Tansey, Tamy C Frank-Cannon, Melissa K McCoy, et al.
ACS Sensors|July 21, 2017
Correction to Insulin Promoter-Driven Gaussia Luciferase-Based Insulin Secretion Biosensor Assay for Discovery of β-Cell Glucose-Sensing PathwaysMichael A Kalwat, Chonlarat Wichaidit, Alejandra Y Nava Garcia, et al.
Pageof 17